Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin.
about
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survivalOsteopontin inhibits mineral deposition and promotes regression of ectopic calcificationNuclear receptors in bone physiology and diseasesFunctional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cellsMechanosensing by the primary cilium: deletion of Kif3A reduces bone formation due to loadingOsteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activitiesThe orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitroHepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway.Absence of ERRalpha in female mice confers resistance to bone loss induced by age or estrogen-deficiencyThrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites.Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1.Prostate cancer and bone: the elective affinities.Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption.Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastasesBiomechanical aspects of the muscle-bone interactionOverride of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion.Impaired bone homeostasis in amyotrophic lateral sclerosis mice with muscle atrophy.Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice.Sympathetic control of bone mass regulated by osteopontin.Effects of Hypergravity on Osteopontin Expression in Osteoblasts.High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes.Hypoxia-mediated efficient expansion of human tendon-derived stem cells in vitro.Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-γ-secreting T-cell Ratios in Bleomycin-treated MicePerlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.Pleiotropic Functions of High Fat Diet in the Etiology of Osteoarthritis.FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.Bone sialoprotein plays a functional role in bone formation and osteoclastogenesisConstitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorptionMatricellular proteins as regulators of cancer metastasis to bone.RANKL, osteopontin, and osteoclast homeostasis in a hyperocclusion mouse model.Osteopontin deficiency enhances parathyroid hormone/ parathyroid hormone related peptide receptor (PPR) signaling-induced alteration in tooth formation and odontoblastic morphologyOsteopontin negatively regulates parathyroid hormone receptor signaling in osteoblastsEvidence for a calcification process in the trabecular meshworkA brief review of bone adaptation to unloading.High serum osteopontin levels are associated with low bone mineral density in postmenopausal women.Adenylyl cyclase 6 mediates loading-induced bone adaptation in vivo.Stability of mRNA influences osteoporotic bone mass via CNOT3.
P2860
Q24672127-17D3A553-7306-4DC4-9A87-D0A78BF0478DQ24684936-C68F76AB-EA8B-44A8-AC12-F1C2F2CB6A07Q26853017-CD510031-0CF7-4223-86E7-C10F07C4FE90Q28236662-F008343F-51C7-46D4-9D56-3D49E2CA4374Q28481462-FACA39DE-D923-4338-B467-E3B27CE7E04DQ28573750-D891D41D-3153-4D4F-ACE8-2D38E7173B76Q28580424-8589E001-111F-463D-873E-218B38D51564Q30426536-C03071AC-DE23-49FA-A6EB-E448EEDB0155Q30912751-036C5CE1-329F-4BC7-841A-01B53951C904Q33328373-7F64BD31-3997-416B-8738-605455DEFD2BQ33569664-DA3B2214-A877-4856-9841-7E9E43D722A1Q33757791-9C406730-D941-4D3B-B619-038458AFA37FQ34268311-7CF83921-52E3-402C-BB2B-4ADD460645EBQ34561406-FE05F474-B15A-426C-A47E-0B83B5B4C27CQ35014005-0063EAD6-FBDB-4E84-B915-30053F82F8A0Q35087950-E19F982F-8056-49AA-BCA4-D3381BEECF88Q35179608-EAE5851C-B35F-451B-89AD-88B7D016BB54Q35221512-0158D5CC-B3C6-41B1-8E88-E67A6D5F3C34Q35229979-35DAFE58-0B05-4A10-87D4-3E943A3018E0Q35470587-9BC7B7EF-8EE5-4EFA-AC7A-CFFD53AFDB5EQ35654181-B4A6F964-9E61-482E-A7EC-CA42BC9ABFB3Q35755147-E04BACFF-1941-4BFE-A24C-09B8A0A416F3Q35778570-097CF4F5-3067-4EBA-9804-B0E2A11FC651Q35802597-70D00035-BF9D-4975-A5F8-0BD8B4EC3886Q35923316-76C7D5B6-0B5C-466C-B1B2-D06406272B77Q35970899-6A99700C-A640-4314-993D-1C7F4D42DA8EQ36128347-3EA706A0-88CD-4DBA-AE8F-C49D22F81378Q36164237-90EA921B-9BC3-4F06-99FD-A17CB161C27BQ36403366-EE0ED2B1-19B2-453B-9400-FBB160889759Q36640021-63E9BDCA-9648-44C3-B164-5BA65DC5B31FQ36677744-674A1641-2D99-4FB9-835B-24F525DA1D6AQ36923653-B290F656-D2ED-4F3C-BEF1-1626B49A7A56Q37002956-A6A92745-C6F6-48AB-884D-B893876A82CCQ37045792-0FC8BAEF-2E6F-4F67-8A38-C882E4AEFCAAQ37145720-6DFAD920-2614-45B5-AAB3-66B9EA8B211CQ37163213-8F79BAB2-DC1C-4A39-B2ED-D12BDCE505F2Q37192886-D9E69B9D-B596-4F61-8D9F-68D15E2361B1Q37220487-45DA390F-2BDB-4150-9D23-21AE7B9F83A2Q37594004-7AF10C46-854F-4E41-850D-F4EB3601B0F7Q37599907-75BD25A3-D54E-4047-AC73-AED113F58B53
P2860
Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Enhancement of osteoclastic bo ...... in the absence of osteopontin.
@ast
Enhancement of osteoclastic bo ...... in the absence of osteopontin.
@en
type
label
Enhancement of osteoclastic bo ...... in the absence of osteopontin.
@ast
Enhancement of osteoclastic bo ...... in the absence of osteopontin.
@en
prefLabel
Enhancement of osteoclastic bo ...... in the absence of osteopontin.
@ast
Enhancement of osteoclastic bo ...... in the absence of osteopontin.
@en
P2093
P2860
P356
P1476
Enhancement of osteoclastic bo ...... in the absence of osteopontin.
@en
P2093
D T Denhardt
H Kurosawa
M Ishijima
S R Rittling
T Yamashita
P2860
P304
P356
10.1084/JEM.193.3.399
P407
P577
2001-02-01T00:00:00Z